通过基菲林酸化状态调节睡眠/清醒模式
Yuan-Chen Tsai1,2, Waleed ElGrawani1,2, Christine Muheim1,2
1Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
The European journal of neuroscience
|July 20, 2024
概括
基菲林酸化通过改变GABAergic突触来调节睡眠. 破坏α1-GABAergic受体显著影响睡眠时间和大脑活动,揭示了睡眠控制的关键分子机制.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 睡眠科学 睡眠科学
背景情况:
- 睡眠/清醒周期对于认知功能至关重要,但分子调节者尚未完全理解.
- GABA活性神经递质对于睡眠至关重要,但具体的GABAA受体亚型和gephyrin的作用尚不清楚.
- 突触变化,特别是酸化,可能为睡眠调节提供目标.
研究的目的:
- 研究α1-和α2-GABAA受体亚型在睡眠调节中的作用.
- 探索gephyrin的功能及其与睡眠/清醒周期中的激酶相互作用.
- 为了确定基菲林酸化是否是睡眠的直接调节者.
主要方法:
- 在没有特定GABAA受体亚型的小鼠中分析睡眠模式和脑电图 (EEG).
- 执行蛋白质组学,以识别与氨酸相互作用的激酶.
- 使用病毒载体来操纵特定突触的酸化gephyrin.
主要成果:
- 缺少α1-GABAA受体显著改变了非REM和REM睡眠持续时间和EEG模式.
- 睡眠/清醒周期调节了葛林与激酶的相互作用,包括ERK1/2.2.
- 在血清268和270的基菲林酸化被确定为关键的睡眠调节剂,而-零变体会扰乱睡眠.
结论:
- α1-GABAA受体在调节NREM和REM睡眠中发挥着核心作用.
- 凝酸化是控制GABAergic突触中的睡眠动态的关键分子机制.
- 这些发现支持局部皮质睡眠假设,并确定了睡眠调节的新途径.
相关概念视频
01:24Sleep-Wake Cycles
1.3K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.3K
02:19Circadian Rhythms and Gene Regulation
4.0K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.0K
01:16Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
02:54Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
163
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
163
01:19Management of Insomnia
239
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
239